In 2024, the U.S. Drug Enforcement Administration (DEA) indicated they plan to reclassify marijuana to be a Schedule III drug. This rescheduling will identify that cannabis has respectable healthcare needs and can help open the doorway to exploration on other opportunity procedure takes advantage of. Read future Organization Insider tells https://thcdisposables.co.uk/